Cytomegalovirus infection in bone marrow-transplant patients Journal Article

  


Authors: Cicogna, C.; Polsky, B.
Article Title: Cytomegalovirus infection in bone marrow-transplant patients
Abstract: Cytomegalovirus (CMV) infection remains a major cause of morbidity and mortality among patients receiving allogeneic bone marrow transplantation. Pneumonia is the most serious manifestation, with an incidence of 15% to 30%. Although the use of ganciclovir with intravenous immunoglobulin has improved survival, CMV pneumonitis is often fatal, underscoring the need for effective prophylaxis.
Keywords: incidence; immunoglobulin; pneumonia; short survey; bone marrow transplantation; foscarnet; ganciclovir; cytomegalovirus infection; intravenous drug administration; oral drug administration; pneumonitis; cytomegalovirus antibody; foscarnet sodium; cancer; human; cytomegalovirus (cmv); cytomegalovirus vaccine
Journal Title: Infections in Medicine
Volume: 11
Issue: 4
ISSN: 0749-6524
Publisher: SCP Communications  
Date Published: 1994-04-01
Start Page: 258, 261
End Page: 262
Language: English
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028296021&partnerID=40&md5=45a094732c52741820926a88b49b48ec
Notes: Short Survey -- Export Date: 14 January 2019 -- Source: Scopus